Status:
UNKNOWN
Individualized Volume of Oral Contrast Agent in CT Enterography
Lead Sponsor:
Shandong University
Conditions:
CTE
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Small bowel distension is mandatory for the assessment of the bowel wall in CT enterography, but some patients were sufferring inadequate small bowel distension. So, it is important to prescribe perso...
Detailed Description
CT enterography has become an important tool in the evaluation of small bowel diseases, especially in patients with inflammatory bowel diseases. Small bowel distension is mandatory for the assessment ...
Eligibility Criteria
Inclusion
- patients undergoing CT enterography
Exclusion
- patients with a history of GI surgery
- patients with known or suspected bowel obstruction or perforation
- patients with severe chronic renal failure (creatinine clearance\<30 ml/min)
- patients with uncontrolled hypertension (systolic blood pressure\>170 mm Hg, diastolic blood pressure\>100 mm Hg)
- patients with acute upper GI bleeding
- patients with severe inflammatory bowel disease or megacolon
- patients with documented allergy to intravascular contrast agent
- patients with pregnancy or lactation
- patients hemodynamically unstable
- patients unable to give informed consent.
Key Trial Info
Start Date :
January 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 20 2019
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03808649
Start Date
January 20 2019
End Date
July 20 2019
Last Update
January 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China, 250012